P L Stetson

452 total citations
23 papers, 389 citations indexed

About

P L Stetson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P L Stetson has authored 23 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P L Stetson's work include Colorectal Cancer Treatments and Studies (4 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer therapeutics and mechanisms (3 papers). P L Stetson is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer therapeutics and mechanisms (3 papers). P L Stetson collaborates with scholars based in United States. P L Stetson's co-authors include William D. Ensminger, Theodore S. Lawrence, Umesh Shukla, Alnawaz Rehemtulla, Melinda R. Wilson, Ernest Hung Yu Ng, James E. Trosko, James A. Knol, J. Robert Sneyd and E. F. Domino and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, International Journal of Radiation Oncology*Biology*Physics and Journal of Chromatography A.

In The Last Decade

P L Stetson

23 papers receiving 371 citations

Peers

P L Stetson
Lisa M. Hollingshead United Kingdom
Kyoko Komatsu Japan
Jay J. Listinsky United States
John C. Lyons United States
Éva Barabás United States
Weiming Ruan United States
L. I. Wiebe Canada
Norimichi Ochi Japan
Esther Fort Spain
Betty Chan United States
Lisa M. Hollingshead United Kingdom
P L Stetson
Citations per year, relative to P L Stetson P L Stetson (= 1×) peers Lisa M. Hollingshead

Countries citing papers authored by P L Stetson

Since Specialization
Citations

This map shows the geographic impact of P L Stetson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P L Stetson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P L Stetson more than expected).

Fields of papers citing papers by P L Stetson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P L Stetson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P L Stetson. The network helps show where P L Stetson may publish in the future.

Co-authorship network of co-authors of P L Stetson

This figure shows the co-authorship network connecting the top 25 collaborators of P L Stetson. A scholar is included among the top collaborators of P L Stetson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P L Stetson. P L Stetson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahoney, Angela, et al.. (2007). Absorption, tissue distribution, metabolism and elimination of taurine given orally to rats. Amino Acids. 32(4). 459–466. 32 indexed citations
2.
Smith, David E., et al.. (1998). Regional pharmacokinetics of 5-fluorouracil in dogs: role of the liver, gastrointestinal tract, and lungs.. PubMed. 58(8). 1688–94. 8 indexed citations
3.
Lawrence, Theodore S., Alnawaz Rehemtulla, Ernest Hung Yu Ng, et al.. (1998). Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine.. PubMed. 58(12). 2588–93. 75 indexed citations
4.
Knol, James A., Suzette Walker, John M. Robertson, et al.. (1995). Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.. PubMed. 55(17). 3687–91. 23 indexed citations
5.
McLaughlin, Patrick W., Theodore S. Lawrence, Nguyen Nguyen, et al.. (1994). Bromodeoxyuridine-mediated radiosensitization in human glioma: The effect of concentration, duration, and fluoropyrimidine modulation. International Journal of Radiation Oncology*Biology*Physics. 30(3). 601–607. 10 indexed citations
6.
Lawrence, Theodore S., Mary A. Davis, P L Stetson, Jonathan Maybaum, & William D. Ensminger. (1994). Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo.. PubMed. 54(11). 2964–8. 10 indexed citations
7.
Stetson, P L, E. F. Domino, & J. Robert Sneyd. (1993). Determination of plasma propofol levels using gas chromatography—mass spectrometry with selected-ion monitoring. Journal of Chromatography B Biomedical Sciences and Applications. 620(2). 260–267. 23 indexed citations
8.
McLaughlin, Patrick W., William R. Mancini, P L Stetson, et al.. (1993). Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. International Journal of Radiation Oncology*Biology*Physics. 26(4). 637–642. 26 indexed citations
9.
Stetson, P L, et al.. (1993). Determination of plasma propofol kevels using gas chromatography-mass spectrometry with selected-ion. 2 indexed citations
10.
Stetson, P L, Umesh Shukla, & William D. Ensminger. (1991). Stability of trimetrexate, a new non-classical antifolate, in infusion solutions. Journal of Chromatography A. 464(1). 163–171. 3 indexed citations
11.
Stetson, P L, et al.. (1991). Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.. PubMed. 51(3). 870–4. 10 indexed citations
12.
Stetson, P L, Daniel P. Normolle, James A. Knol, et al.. (1991). Biochemical Modulation of 5-Bromo-2'-deoxyuridine and 5-Iodo-2'-deoxyuridine Incorporation Into DNA in VX2 Tumor-Bearing Rabbits. JNCI Journal of the National Cancer Institute. 83(22). 1659–1667. 11 indexed citations
13.
Thornton, Allan F., William F. Chandler, William D. Ensminger, et al.. (1990). Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas. International Journal of Radiation Oncology*Biology*Physics. 19(2). 421–428. 41 indexed citations
14.
Stetson, P L, Zhuo Yang, & William D. Ensminger. (1989). Pharmacodynamics of 5-Iodo-2'-deoxyuridine in VX2 Tumor-Bearing Rabbits. JNCI Journal of the National Cancer Institute. 81(24). 1925–1926. 2 indexed citations
15.
16.
Stetson, P L, Jonathan Maybaum, John G. Wagner, et al.. (1988). Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.. PubMed. 48(23). 6900–5. 10 indexed citations
17.
Stetson, P L & William D. Ensminger. (1986). Determination of plasma trimetrexate levels using gas chromatography—mass spectrometry with selected-ion monitoring. Journal of Chromatography B Biomedical Sciences and Applications. 383(1). 69–76. 21 indexed citations
18.
Wollner, Ira, John E. Niederhuber, Jack E. Juni, et al.. (1986). A dog model using an implanted system for protracted hepatic arterial chemotherapy. Journal of Surgical Research. 41(5). 510–517. 5 indexed citations
19.
Stetson, P L, Umesh Shukla, & William D. Ensminger. (1985). Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 344. 385–390. 34 indexed citations
20.
Morais, José, Robert A. Zlotecki, Ermelinda Sakmar, P L Stetson, & J. Wagner. (1981). Specific and sensitive assays for digoxin in plasma, urine and heart tissue.. PubMed. 31(2). 285–98. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa M. Hollingshead Breakdown of academic impact, for papers by Kyoko Komatsu Breakdown of academic impact, for papers by Jay J. Listinsky Breakdown of academic impact, for papers by John C. Lyons Breakdown of academic impact, for papers by Éva Barabás Breakdown of academic impact, for papers by Weiming Ruan Breakdown of academic impact, for papers by L. I. Wiebe Breakdown of academic impact, for papers by Norimichi Ochi Breakdown of academic impact, for papers by Esther Fort Breakdown of academic impact, for papers by Betty Chan
Rankless by CCL
2026